Table S5 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma

Table S5 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma

<p>List of recurrent mutations with potential utility as neoantigens</p>

Saved in:

書目詳細資料
主要作者:	Lijun Yao (15292963) (author)
其他作者:	Julia T. Wang (15292966) (author), Reyka G. Jayasinghe (15131798) (author), Julie O'Neal (15292969) (author), Chia-Feng Tsai (15292972) (author), Michael P. Rettig (15292975) (author), Yizhe Song (15292978) (author), Ruiyang Liu (15292981) (author), Yanyan Zhao (15292984) (author), Omar M. Ibrahim (15292987) (author), Mark A. Fiala (15032471) (author), Julie M. Fortier (15292990) (author), Siqi Chen (15292993) (author), Leah Gehrs (15292996) (author), Fernanda Martins Rodrigues (15292999) (author), Michael C. Wendl (15293002) (author), Daniel Kohnen (15293005) (author), Andrew Shinkle (15293008) (author), Song Cao (15293011) (author), Steven M. Foltz (15293014) (author), Daniel Cui Zhou (15293017) (author), Erik Storrs (15293020) (author), Matthew A. Wyczalkowski (15293023) (author), Smrithi Mani (15293026) (author), Scott R. Goldsmith (15293029) (author), Ying Zhu (15293032) (author), Mark Hamilton (15131831) (author), Tao Liu (15293035) (author), Feng Chen (15293038) (author), Ravi Vij (15293041) (author), Li Ding (15061726) (author), John F. DiPersio (15293044) (author)
出版:	2025
主題:	Cancer Immuno-oncology Methods and Technology Hematological Cancers Myelomas Immunotherapy Single Cell Technologies
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Table S1 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
由: Lijun Yao (15292963)
出版: (2025)

Table S2 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
由: Lijun Yao (15292963)
出版: (2025)

Table S3 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
由: Lijun Yao (15292963)
出版: (2025)

Table S4 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
由: Lijun Yao (15292963)
出版: (2025)

Table S6 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
由: Lijun Yao (15292963)
出版: (2025)

Supplementary Spreadsheet S5 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
由: Eileen M. Boyle (15015425)
出版: (2025)

Supplementary Spreadsheet S1 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
由: Eileen M. Boyle (15015425)
出版: (2025)

Supplementary Spreadsheet S10 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
由: Eileen M. Boyle (15015425)
出版: (2025)

Supplementary Spreadsheet S11 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
由: Eileen M. Boyle (15015425)
出版: (2025)

Supplementary Spreadsheet S12 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
由: Eileen M. Boyle (15015425)
出版: (2025)

Supplementary Spreadsheet S2 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
由: Eileen M. Boyle (15015425)
出版: (2025)

Supplementary Spreadsheet S3 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
由: Eileen M. Boyle (15015425)
出版: (2025)

Supplementary Spreadsheet S4 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
由: Eileen M. Boyle (15015425)
出版: (2025)

Supplementary Spreadsheet S6 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
由: Eileen M. Boyle (15015425)
出版: (2025)

Supplementary Spreadsheet S7 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
由: Eileen M. Boyle (15015425)
出版: (2025)

Supplementary Spreadsheet S8 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
由: Eileen M. Boyle (15015425)
出版: (2025)

Supplementary Spreadsheet S9 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
由: Eileen M. Boyle (15015425)
出版: (2025)

Supplementary Data S1 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
由: Keiji Kurata (15055090)
出版: (2025)

Supplementary Data S2 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
由: Keiji Kurata (15055090)
出版: (2025)

Supplementary Data S3 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
由: Keiji Kurata (15055090)
出版: (2025)

Supplementary Table 5 from Super Enhancer-Mediated Upregulation of <i>HJURP</i> Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma
由: Yunlu Jia (2012017)
出版: (2025)

Supplementary Table 1 from Super Enhancer-Mediated Upregulation of <i>HJURP</i> Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma
由: Yunlu Jia (2012017)
出版: (2025)

Supplementary Table 2 from Super Enhancer-Mediated Upregulation of <i>HJURP</i> Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma
由: Yunlu Jia (2012017)
出版: (2025)

Supplementary Table 3 from Super Enhancer-Mediated Upregulation of <i>HJURP</i> Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma
由: Yunlu Jia (2012017)
出版: (2025)

Supplementary table 5 from Single-Cell Transcriptomics Reveals Immune Reconstitution in Patients with R/R T-ALL/LBL Treated with Donor-Derived CD7 CAR-T Therapy
由: Wei Chen (15053713)
出版: (2025)

Supplementary table 6 from Single-Cell Transcriptomics Reveals Immune Reconstitution in Patients with R/R T-ALL/LBL Treated with Donor-Derived CD7 CAR-T Therapy
由: Wei Chen (15053713)
出版: (2025)

Supplementary table 7 from Single-Cell Transcriptomics Reveals Immune Reconstitution in Patients with R/R T-ALL/LBL Treated with Donor-Derived CD7 CAR-T Therapy
由: Wei Chen (15053713)
出版: (2025)

Discovery and Characterization of Novel BLIMP‑1 Heterobifunctional Ligand-Directed Degraders
由: Bryan J. Simmons (22676881)
出版: (2025)

Supplementary Data from NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy
由: Ti Wen (15130158)
出版: (2025)

Correlation between duration of first-line treatment with daratumumab, lenalidomide, and dexamethasone and overall survival in patients with transplant-ineligible multiple myeloma in Japan
由: Kazuhito Suzuki (22688384)
出版: (2025)

Supplementary Table S1 from Integrative Single-Cell and Bulk Transcriptomes Analyses Identify Intrinsic HNSCC Subtypes with Distinct Prognoses and Therapeutic Vulnerabilities
由: Yibin Dai (16374331)
出版: (2025)

Supplementary Table S2 from Integrative Single-Cell and Bulk Transcriptomes Analyses Identify Intrinsic HNSCC Subtypes with Distinct Prognoses and Therapeutic Vulnerabilities
由: Yibin Dai (16374331)
出版: (2025)

Table S5 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
由: Stéphane Fattori (15048281)
出版: (2025)

Supplementary Tables S1-S11 from Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic <i>TP53</i>-Mutant Clonal Hematopoiesis
由: Rathana Kim (15135915)
出版: (2025)

File_S1 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
由: Stéphane Fattori (15048281)
出版: (2025)

Table S1 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
由: Stéphane Fattori (15048281)
出版: (2025)

Table S2 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
由: Stéphane Fattori (15048281)
出版: (2025)

Table S3 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
由: Stéphane Fattori (15048281)
出版: (2025)

Table S4 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
由: Stéphane Fattori (15048281)
出版: (2025)

Table S6 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
由: Stéphane Fattori (15048281)
出版: (2025)

Cannot write session to /tmp/vufind_sessions/sess_k2mjk8brgko78ccelop1r5gh6i